organization · Reporting owner
Health Wildcatters, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Lantern Pharma Inc.
Report date January 14, 2021 · Filed January 19, 2021
Jointly reported with Green Park & Golf Ventures II, LLC, Green Park & Golf Ventures, LLC, GPG LPI Investment, LLC, Lantern 3-19 Investment, LLC, Health Wildcatters Fund II, LLC, Soderstrom Carl D, Heighten Clay M, Garcia Gilbert G. II
Section 16 reporting ended · disclosed 2021-01-19. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2020 Filed Jun 17, 2020 21:35 UTC | Lantern Pharma Inc. LTRN · Entity 7525 | ConversionSeries A Preferred Stock, par value $0.01 · Derivative | 75,688 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-016898 · doc4.xml · derivative · entry 6 Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner GPG LPI Investment, LLC · CIK 0001814288 · 10% owner Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner Health Wildcatters, LLC · CIK 0001814291 · 10% owner Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner Garcia Gilbert G. II · CIK 0001814289 · 10% owner Heighten Clay M · CIK 0001599114 · 10% owner Soderstrom Carl D · CIK 0001598985 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 131,697 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: In connection with the Initial Public Offering, approximately 75,688 shares of Series A Preferred Stock directly held by Lantern 3-19, which had no expiration date, were automatically converted into 131,697 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F7 · price: In connection with the Initial Public Offering, approximately 75,688 shares of Series A Preferred Stock directly held by Lantern 3-19, which had no expiration date, were automatically converted into 131,697 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F7 · derivative.exercise_date: In connection with the Initial Public Offering, approximately 75,688 shares of Series A Preferred Stock directly held by Lantern 3-19, which had no expiration date, were automatically converted into 131,697 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F7 · derivative.expiration_date: In connection with the Initial Public Offering, approximately 75,688 shares of Series A Preferred Stock directly held by Lantern 3-19, which had no expiration date, were automatically converted into 131,697 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F4 · derivative.underlying_shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split. F3 · ownership.nature: These securities are directly held by Lantern 3-19 Investment, LLC ("Lantern 3-19"). Carl D. Soderstrom, Clay M. Heighten, M.D., and Gilbert G. Garcia II are the managing members of Green Park & Golf Ventures II, LLC ("GPG II"), which is the managing member Lantern 3-19. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., Gilbert G. Garcia II, and GPG II may be deemed to beneficially own these securities. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:35 UTC | Lantern Pharma Inc. LTRN · Entity 7525 | ConversionSeries A Preferred Stock, par value $0.01 · Derivative | 168,164 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-016898 · doc4.xml · derivative · entry 5 Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner GPG LPI Investment, LLC · CIK 0001814288 · 10% owner Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner Health Wildcatters, LLC · CIK 0001814291 · 10% owner Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner Garcia Gilbert G. II · CIK 0001814289 · 10% owner Heighten Clay M · CIK 0001599114 · 10% owner Soderstrom Carl D · CIK 0001598985 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 292,605 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: In connection with the Initial Public Offering, 168,164 shares of Series A Preferred Stock directly held by GPG LPI, which had no expiration date, were automatically converted into 292,605 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F6 · price: In connection with the Initial Public Offering, 168,164 shares of Series A Preferred Stock directly held by GPG LPI, which had no expiration date, were automatically converted into 292,605 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F6 · derivative.exercise_date: In connection with the Initial Public Offering, 168,164 shares of Series A Preferred Stock directly held by GPG LPI, which had no expiration date, were automatically converted into 292,605 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F6 · derivative.expiration_date: In connection with the Initial Public Offering, 168,164 shares of Series A Preferred Stock directly held by GPG LPI, which had no expiration date, were automatically converted into 292,605 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F4 · derivative.underlying_shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split. F2 · ownership.nature: These securities are directly held by GPG LPI Investment, LLC ("GPG LPI"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of GPG, which is the managing member GPG LPI. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., and GPG may be deemed to beneficially own these securities. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:35 UTC | Lantern Pharma Inc. LTRN · Entity 7525 | ConversionSeries A Preferred Stock, par value $0.01 · Derivative | 23,871 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-016898 · doc4.xml · derivative · entry 4 Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner GPG LPI Investment, LLC · CIK 0001814288 · 10% owner Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner Health Wildcatters, LLC · CIK 0001814291 · 10% owner Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner Garcia Gilbert G. II · CIK 0001814289 · 10% owner Heighten Clay M · CIK 0001599114 · 10% owner Soderstrom Carl D · CIK 0001598985 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 41,535 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: In connection with the Initial Public Offering, 23,871 shares of the Issuer's Series A Preferred Stock, par value $0.01 ("Series A Preferred Stock"), directly held by HWF II, which had no expiration date, were automatically converted into 41,535 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F5 · price: In connection with the Initial Public Offering, 23,871 shares of the Issuer's Series A Preferred Stock, par value $0.01 ("Series A Preferred Stock"), directly held by HWF II, which had no expiration date, were automatically converted into 41,535 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F5 · derivative.exercise_date: In connection with the Initial Public Offering, 23,871 shares of the Issuer's Series A Preferred Stock, par value $0.01 ("Series A Preferred Stock"), directly held by HWF II, which had no expiration date, were automatically converted into 41,535 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F5 · derivative.expiration_date: In connection with the Initial Public Offering, 23,871 shares of the Issuer's Series A Preferred Stock, par value $0.01 ("Series A Preferred Stock"), directly held by HWF II, which had no expiration date, were automatically converted into 41,535 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F4 · derivative.underlying_shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split. F1 · ownership.nature: These securities are directly held by Health Wildcatters Fund II, LLC ("HWF II"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of Green Park & Golf Ventures, LLC ("GPG"), which is the managing member of Health Wildcatters, LLC ("HW"), which is the managing member of HWF II. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., GPG, and HW may be deemed to beneficially own these securities. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:35 UTC | Lantern Pharma Inc. LTRN · Entity 7525 | ConversionCommon Stock, par value $0.0001 | 131,697 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-016898 · doc4.xml · nonDerivative · entry 3 Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner GPG LPI Investment, LLC · CIK 0001814288 · 10% owner Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner Health Wildcatters, LLC · CIK 0001814291 · 10% owner Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner Garcia Gilbert G. II · CIK 0001814289 · 10% owner Heighten Clay M · CIK 0001599114 · 10% owner Soderstrom Carl D · CIK 0001598985 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 131,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split. F7 · price: In connection with the Initial Public Offering, approximately 75,688 shares of Series A Preferred Stock directly held by Lantern 3-19, which had no expiration date, were automatically converted into 131,697 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F3 · ownership.nature: These securities are directly held by Lantern 3-19 Investment, LLC ("Lantern 3-19"). Carl D. Soderstrom, Clay M. Heighten, M.D., and Gilbert G. Garcia II are the managing members of Green Park & Golf Ventures II, LLC ("GPG II"), which is the managing member Lantern 3-19. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., Gilbert G. Garcia II, and GPG II may be deemed to beneficially own these securities. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:35 UTC | Lantern Pharma Inc. LTRN · Entity 7525 | ConversionCommon Stock, par value $0.0001 | 292,605 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-016898 · doc4.xml · nonDerivative · entry 2 Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner GPG LPI Investment, LLC · CIK 0001814288 · 10% owner Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner Health Wildcatters, LLC · CIK 0001814291 · 10% owner Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner Garcia Gilbert G. II · CIK 0001814289 · 10% owner Heighten Clay M · CIK 0001599114 · 10% owner Soderstrom Carl D · CIK 0001598985 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 292,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split. F6 · price: In connection with the Initial Public Offering, 168,164 shares of Series A Preferred Stock directly held by GPG LPI, which had no expiration date, were automatically converted into 292,605 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F2 · ownership.nature: These securities are directly held by GPG LPI Investment, LLC ("GPG LPI"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of GPG, which is the managing member GPG LPI. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., and GPG may be deemed to beneficially own these securities. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:35 UTC | Lantern Pharma Inc. LTRN · Entity 7525 | ConversionCommon Stock, par value $0.0001 | 41,535 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-016898 · doc4.xml · nonDerivative · entry 1 Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner GPG LPI Investment, LLC · CIK 0001814288 · 10% owner Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner Health Wildcatters, LLC · CIK 0001814291 · 10% owner Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner Garcia Gilbert G. II · CIK 0001814289 · 10% owner Heighten Clay M · CIK 0001599114 · 10% owner Soderstrom Carl D · CIK 0001598985 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 211,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split. F5 · price: In connection with the Initial Public Offering, 23,871 shares of the Issuer's Series A Preferred Stock, par value $0.01 ("Series A Preferred Stock"), directly held by HWF II, which had no expiration date, were automatically converted into 41,535 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering. F1 · ownership.nature: These securities are directly held by Health Wildcatters Fund II, LLC ("HWF II"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of Green Park & Golf Ventures, LLC ("GPG"), which is the managing member of Health Wildcatters, LLC ("HW"), which is the managing member of HWF II. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., GPG, and HW may be deemed to beneficially own these securities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.